Keynotes

Keynote Speakers

Dr. David Erickson

Keynote Speaker

S.C. Thomas Sze Director of the Sibley School of Mechanical and Aerospace Engineering
Sibley School of Mechanical and Aerospace Engineering
Cornell University
Website: https://www.engineering.cornell.edu/faculty-directory/david-erickson

David Erickson is the SC Thomas Sze Director and Sibley College Professor in the Sibley School of Mechanical and Aerospace Engineering at Cornell University. He is also a joint Professor within the Division of Nutritional Sciences and was previously the Associate Dean of Engineering for Research and Graduate Programs. Prof. Erickson is the director of the NIH POCTRN Center “PORTENT – Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health.” His research focuses on: global health technology, medical diagnostics, microfluidics, photonics, and nanotechnology. Prior to joining the faculty, he was a postdoctoral scholar at the California Institute of Technology and he received his Ph.D. degree from the University of Toronto. Research in the Erickson lab is or has been primarily funded through grants from the NIH, NSF, ARPA-E, ONR, DoD, DOE, DARPA, USAID, USDA, Nutrition International, Global Alliance for Improved Nutrition, and other foundations. Prof. Erickson has helped to found numerous start-up companies commercializing: high-throughput pharmaceutical instrumentation, biomedical diagnostics, and energy technologies including Halo Labs, VitaScan and Dimensional Energy.

Dr. Ashutosh Chilkoti

Keynote Speaker

Alan L. Kaganov Distinguished Professor of Biomedical Engineering
Duke University
Website: https://chilkotilab.pratt.duke.edu/members/chilkoti

Ashutosh Chilkoti is the Alan L. Kaganov Professor of Biomedical Engineering and Chair of the Department of Biomedical Engineering at Duke University. His research in biomolecular engineering and biointerface science focuses on the development of new molecular tools and technologies that borrow from molecular biology, protein engineering, polymer chemistry and surface science, for applications that span the range from bioseparations, plasmonic biosensors, low-cost clinical diagnostics, and drug delivery.

Dr. Samuel Sia

Keynote Speaker

Professor of Biomedical Engineering.
Vice-Provost for the fourth purpose and strategic impact.
Columbia University
Website: https://www.engineering.columbia.edu/faculty/sam-sia

Samuel Sia develops technologies for point-of-care blood tests, wearable sensors, and implantable devices, both in an academic and industry setting. He co-developed a point-of-care blood test for prostate cancer which has garnered FDA approval, and is co-founder of Rover Diagnostics which is developing rapid and low-cost detection of DNA and RNA.

Dr. Yukari Manabe

Keynote Speaker

Professor in Department of Medicine (Infectious Diseases Division).
Associate Director of Global Health Research and Innovation.
Medical Director, John G. Bartlett Specialty Practice.
Johns Hopkins University
Website: https://tbcenter.jhu.edu/facultymember/yukari-manabe-md/

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999.
Dr. Manabe has been doing operational and translational research in tuberculosis and HIV co-infection as well as evaluating TB and other infectious disease diagnostics. She is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. She is also interested in studying the impact of various diagnostic interventions on disease detection and patient outcomes.